+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Discovery Market Research Reports

From
Thin Film Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Thin Film Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biosimulation Market - Product Thumbnail Image

Biosimulation Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Crovalimab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Crovalimab Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
LNP023 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LNP023 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Nedosiran Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Nedosiran Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • July 2023
  • 30 Pages
  • Global
From
Etrasimod Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Etrasimod Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
VTX-801 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

VTX-801 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
UX701 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

UX701 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Lomitapide Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lomitapide Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SKYRIZI Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SKYRIZI Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Mirikizumab Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Mirikizumab Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
TREMFYA Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TREMFYA Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
SHR0302 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

SHR0302 Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Inavolisib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Inavolisib Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Camizestrant Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Camizestrant Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Lerociclib Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Lerociclib Emerging Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • January 2023
  • 30 Pages
  • Global
From
Loading Indicator

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs. The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more